Comprehensive Metabolic Panel Testing Market by Diseases (Kidney Disease, Liver Disease, Diabetes, and Others), End-users (Laboratories and PoC), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global comprehensive metabolic panel testing market size is estimated to expand at a considerable CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the increased prevalence of chronic illnesses as well as the rising preference for early detection and treatment among the health-conscious population.
A comprehensive metabolic panel (CMP) includes a collection of several blood tests that can help examine substances present in the blood. These blood tests are basically performed to examine some key features such as kidney and liver functioning, sugar level, and nutrient balance. The tests can easily detect if there is high sugar level or any disorder in the kidney or liver functioning of a patient. For instance, CMP glucose test can assess the level of glucose in the blood and can confirm if a patient is suffering from diabetes (high glucose level) or hypoglycemia (low sugar level). The key purpose for the adoption of a CMP is to assess a board analysis regarding the existing physical fitness or well-being of people. Additionally, a CPM is widely used for various medical applications including screening, monitoring, and diagnosis of several health conditions and the aftermath treatment process.
Rising cases of chronic illness such as diabetes and kidney diseases are mainly caused by the high frequency of lifestyle-related disorders, impacted by the prevalence of smoking and bad eating habits. Lack of physical exercise and inactive lifestyle are among the reasons contributing to the rise in chronic disease incidence.
Market Trends, Drivers, Restraints, and Opportunities:
- Increasing number of patients suffering from chronic illness especially diabetes and high preference for the prevention from such diseases are expected to boost the market expansion.
- Growing per capita income and rising health fitness concerns from a large number of the global population are key drivers of the market.
- Expanding the healthcare infrastructure and improving point of care facilities along with the rapid development of diagnostic kits for several diseases present key factors that can expand the market growth.
- Introduction of novel methods and techniques for increasing accuracy and efficiency in the results of CMP testing are another key factors fueling the market growth.
- Development and implementation of different bioinformatics and data management solutions along with the rise of automated systems in laboratories are key opportunities for the market expansion.
- Strict reimbursement policy and regulatory organizations applying rigorous regulations are some major challenges that can hamper the market expansion.
Scope of the Report
The report on the global comprehensive metabolic panel testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Comprehensive Metabolic Panel Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Diseases (Kidney Disease, Liver Disease, Diabetes, and Others), and End-users (Laboratories and PoC) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Sonic Healthcare, UNIPATH, and SYNLAB International GmbH |
Market Segment Insights
Kidney diseases segment to hold a key market share
Based on diseases, the global comprehensive metabolic panel testing market is divided into kidney disease, liver disease, diabetes, and others. The kidney disease segment is expected to account for a key share of the market in the coming years due to high rate of illness related to kidney disorders worldwide and rising demand for maximum analytical use from kidney patients. Other comorbidities such as diabetes and excessive blood pressure may be caused due to renal abnormalities. Meanwhile, the diabetes segment is anticipated to grow at a significant rate due to rising numbers of the patients having a history of cardiovascular disease or diabetes. The absence of early symptoms makes early illness diagnosis difficult.
Laboratories segment to constitute a large share
On the basis of end-users, the market is divided into laboratories, and PoC. The laboratories segment is projected to constitute a large market share during the forecast period owing to easy availability, strong market penetration, expanding usage, and clinically noteworthy effects of laboratory centers. Some laboratories are extensively linked up and associated with hospitals, blood banks, and specialist diagnostic institutions to increase their leverage of services. Furthermore, the widespread availability of auxiliary support both in terms of labor and infrastructure is a crucial driver for the market expansion.
On the other hand, the PoC segment is expected to expand rapidly in the coming years owing to its ease of use, portability, speed of results, and lower sample required. Rising customer demand for enhanced and faster diagnostics and wide adoption of advanced technology for laboratory testing of CMP are expected to boost the segment growth.
North America is anticipated to register a robust CAGR
Based on regions, the global comprehensive metabolic panel testing market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to register a robust CAGR during the forecast period due to the excellent commercial success of CMP diagnostics especially in the US. High illness burden, increased consumer awareness, aggressive government actions, technology breakthroughs, and improvements in healthcare infrastructure are some prominent drivers for the regional market expansion. Furthermore, the presence of major global companies in the region is another key factor for the market expansion in North America.
Meanwhile, the market in Asia Pacific is predicted to grow at a fast CAGR during the projected period owing to improvements in healthcare infrastructure, more consumer awareness, rising disposable income, and overall economic development. During the period, the demand for CMP testing is likely to increase rapidly in these emerging markets such as China, India, and South Korea.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Comprehensive Metabolic Panel Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Comprehensive Metabolic Panel Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Comprehensive Metabolic Panel Testing Market - Supply Chain
4.5. Global Comprehensive Metabolic Panel Testing Market Forecast
4.5.1. Comprehensive Metabolic Panel Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Comprehensive Metabolic Panel Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Comprehensive Metabolic Panel Testing Market Absolute $ Opportunity
5. Global Comprehensive Metabolic Panel Testing Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
5.3.1. Laboratories
5.3.2. PoC
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Comprehensive Metabolic Panel Testing Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
7. North America Comprehensive Metabolic Panel Testing Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
7.4.1. Laboratories
7.4.2. PoC
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
8. Latin America Comprehensive Metabolic Panel Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
8.4.1. Laboratories
8.4.2. PoC
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
9. Europe Comprehensive Metabolic Panel Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
9.4.1. Laboratories
9.4.2. PoC
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Comprehensive Metabolic Panel Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
10.4.1. Laboratories
10.4.2. PoC
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Comprehensive Metabolic Panel Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Comprehensive Metabolic Panel Testing Market Size and Volume Forecast by End Users
11.4.1. Laboratories
11.4.2. PoC
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Comprehensive Metabolic Panel Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Comprehensive Metabolic Panel Testing Market: Market Share Analysis
12.2. Comprehensive Metabolic Panel Testing Distributors and Customers
12.3. Comprehensive Metabolic Panel Testing Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott
12.4.2. Quest Diagnostics
12.4.3. Laboratory Corporation of America Holdings (LabCorp)
12.4.4. Sonic Healthcare
12.4.5. UNIPATH
12.4.6. SYNLAB International GmbH B
Segments Covered in the Report
The global comprehensive metabolic panel testing market has been segmented on the basis of
Diseases
- Kidney Disease
- Liver Disease
- Diabetes
- Others
End-users
- Laboratories
- PoC
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- Quest Diagnostics
- Laboratory Corporation of America Holdings (LabCorp)
- Sonic Healthcare
- UNIPATH
- SYNLAB International GmbH B
Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Sonic Healthcare, UNIPATH, and SYNLAB International GmbH are the key players leading the market. Many of these competitors are consistently focusing on strategic efforts such as product launches and development, mergers and acquisitions, licensing alliances, and co-development arrangements to enhance their market positions.
Our Clients
Related Reports
Some other reports from this category!
